Popular, Inc.

NASDAQ: BPOP
$77.81
-$2.79 (-3.5%)
Closing price May 18, 2022
Many traders and investors love the active penny-stocks and low-priced stocks, and the short interest is often used as a measure for or against the shares of the active cult stocks.  The short...
These are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Allegheny Technologies Inc. (NYSE: ATI) Raised to Buy at BofA/Merrill...
Many traders and investors love the active penny-stocks and low-priced stocks, and the short interest is often used as a measure for or against the shares of the active cult stocks.  The short...
Many traders and investors love the active penny-stocks and low-priced stocks.  And betting against low-priced shares is something that expert short sellers frequently do.  The short selling from...
Monday is so far turning out to be one of those days where news here may not matter much as far as stocks on the move.  This is all about the $1 trillion E.U. bailout and the turnaround snap-back...
Next week is still a deep earnings week, but we tried and tried to keep this weekend’s edition of The Unusual Suspects as free and clear from earnings as we could.  There are some macro-issues as...
Twitter has, by most estimates, 75 million visitors a month, which makes it one of the largest social networks in the world. All major media companies are on Twitter and some have more than one...
These are the top day trader and active trader alerts seen in action this morning.  We have details in the links over at VSInvestor.com with more details and analysis on each where applicable. Ambac...
These are Wednesday’s top ten analyst research summary upgrades, downgrades, and initiations from Wall Street brokerage firms: Abercrombie & Fitch (NYSE: ANF) Cut to Neutral at Susquehanna....
ViroPharma (VPHM) Drug trial fails. Huge drop to $4.89 from 52-week high of $15.16. Insight Enterprises (NSIT) Plans to restate earnings. Falls to $2.69 from 52-week high of $19.25. Popular Inc...
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI) Housing and mortgage markets hurt quarter. Falls to $22.80 from 52-week high of $51.46....